English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1091]
News [2734]
Articles [183]
Editorials [9]
Conferences [110]
elearning [25]
For early prostate cancer ‘active surveillance’ is now the number one choice
For early prostate cancer ‘active surveillance’ is now the number one choice
Researchers develop strategy for capturing cancer-specific protein interactions
Researchers develop strategy for capturing cancer-specific protein interactions
Study links ultra-processed foods to significantly higher prostate cancer risks
Study links ultra-processed foods to significantly higher prostate cancer risks
PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumour
PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumour
What is the optimal prostate-specific antigen cutoff to determine the success of prostate cancer treatment?
What is the optimal prostate-specific antigen cutoff to determine the success of prostate cancer treatment?
Ferroptosis and prostate cancer: translating iron-dependent cell death into precision oncology
Ferroptosis and prostate cancer: translating iron-dependent cell death into precision oncology
Combination of targeted therapies could help overcome treatment resistance in advanced prostate cancer
Combination of targeted therapies could help overcome treatment resistance in advanced prostate cancer
Experimental immunotherapy may help patients with high-risk bladder cancer avoid bladder removal surgery
Experimental immunotherapy may help patients with high-risk bladder cancer avoid bladder removal surgery
Casdatifan demonstrates durable tumour responses in heavily pretreated patients with advanced kidney cancer, study shows
Casdatifan demonstrates durable tumour responses in heavily pretreated patients with advanced kidney cancer, study...
New mechanoresistant cancer cells show how they survive high stress environments
New mechanoresistant cancer cells show how they survive high stress environments
<12345…274>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2026 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top